BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies
Latest Information Update: 29 Aug 2021
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BENEFIT 15
- Sponsors Bayer
- 26 May 2020 Results evaluating the employment status and associated outcomes, presented at the 6th Congress of the European Academy of Neurology.
- 25 Jun 2018 Status changed from recruiting to completed.
- 21 Jun 2018 This trial has been completed in Czech Republic (2018-05-24), according to European Clinical Trials Database